Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $3

Maxim Group analyst Anthony Vendetti maintains $Icecure Medical(ICCM.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 30.3% an

Futu NewsJun 6 02:31

H.C. Wainwright Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $3

H.C. Wainwright analyst Yi Chen maintains $Icecure Medical(ICCM.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 27.2% and a t

Futu NewsJun 5 18:33

IceCure Medical (ICCM) Moves to Buy: Rationale Behind the Upgrade

Yahoo FinanceJun 5 00:00

IceCure Medical Announces FDA Advisory Panel Meeting To Review ProSense System For Tumor Cryoablation

IceCure Medical Announces FDA Advisory Panel Meeting To Review ProSense System For Tumor Cryoablation

BenzingaJun 4 20:35

Express News | Icecure Medical Ltd: Advisory Panel Is Expected to Convene in Q4 of 2024, With an FDA Decision on Whether to Approve Prosense® Expected by Early 2025

BreakingsJun 4 20:30

Express News | FDA to Convene Advisory Panel for Review of Icecure's De Novo Marketing Clearance Request for Prosense®, Decision Expected Early 2025; Aligns With Commercial Readiness Plan

BreakingsJun 4 20:30